¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reactive systemic amyloidosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® amyloidosis ÇÑ±Û ¾Æ¹Ð·ÎÀ̵åÁõ
¼³¸í   
  º»·¡ »ýü¿¡´Â ¾ø´Â ´ç´Ü¹éÁúÀÇ ÀÏÁ¾À¸·Î ºñÁ¤»óÀûÀ¸·Î ¾Æ¹Ð·ÎÀ̵å´Ü¹éÀÌ Á¶Á÷À̳ª Àå±â¿¡ Ä§ÂøµÇ´Â º´. ¹ßÇöºÎÀ§°¡ Àü½Å¼ºÀΠ°æ¿ìÀÇ ¾Æ¹Ð·ÎÀ̵åÁõ(Àü½Å¼º ¾Æ¹Ð·ÎÀ̵åÁõ)¿¡´Â ¸í¹éÇÑ ¿øÀξøÀÌ ÀϾ´Â ¿ø¹ß¼º ¾Æ¹Ð·ÎµåÁõ°ú ¸¸¼ºÈ­³ó¼º ¿°ÁõÀ̳ª °áÇÙ µî ¼Ò¸ð¼º Áúȯ¿¡¼­ Ã£¾Æº¼ ¼ö Àִ ¼Ó¹ß¼º ¾Æ¹Ð·ÎÀ̵åÁõÀÌ ÀÖ´Ù. ¹ßÇöºÎÀ§°¡ ±¹¼Ò¼ºÀΠ°æ¿ìÀÇ ±¹¼Ò¼º ¾Æ¹Ð·ÎÀ̵åÁõÀ¸·Î¼­´Â ³úÀÇ ³ëÀιÝÀÌ ±× ¿¹À̸ç, Æ¯È÷ ÀԾȿ¡¼­´Â Çô³ª ÀÕ¸ö¿¡ ´ëÇÑ Ä§ÂøÀÌ ÇöÀúÇÏ°í ¿©·¯ °¡Áö ±â´ÉÀå¾Ö¸¦ ³ªÅ¸³½´Ù. Á¶Á÷ÇÐÀûÀ¸·Î´Â Ç츶Åå½Ç¸° ¿¡¿ÀÁø¿°»ö¿¡¼­´Â ¿¡¿ÀÁø¼º ¹«±¸Á¶ÀΠÀ¯¸®È­¸¦ ³ªÅ¸³»¸ç Äá°í·¹µå, Æí±¤»ó(³ì»ö) µîÀ¸·Î È®ÀÎÇÑ´Ù. ±¸Á¶ÀûÀ¸·Î´Â ¾Æ¹Ð·ÎÀ̵堼¶À¯ÀÇ ÁýÇÕÀ¸·Î ÀÌ·ç¾îÁö´Â ¿©·¯ °¡Áö ¾Æ¹Ð·ÎÀ̵å Ä§ÂøÀÌ ÀÖÀ¸¸ç ±×°Íµé¿¡ ´ëÇÑ º´ÇüÀÌ ºÐ·ùµÇ¾î ÀÖ´Ù. °¡Á·Çü, ´Ù¹ß¼º °ñ¼öÁ¾°ú ¼ö¹ÝÇϴ Çü ±×¸®°í °¡Á·¼º ÁöÁßÇØ¿­À» ¼ö¹ÝÇϴ Çü µîÀÌ ÀÖ´Ù.
¿µ¹® systemic lupus erythematosus ÇÑ±Û Àü½ÅÈ«¹Ý·çǪ½º
¼³¸í   
  Àü½Å ÀÚ°¡¸é¿ªº´ÀÇ ´ëÇ¥Àû º´ÀÌ´Ù. ¿©¼º¿¡°Ô ¾ÐµµÀûÀ¸·Î ¸¹°í, 10~39¼¼±îÁö°¡ 70%¸¦ Â÷ÁöÇÑ´Ù. ¿øÀÎÀº Àß ¸ð¸£³ª ÀÚ°¡¸é¿ª Á¶Àý±â´É¿¡ Àå¾Ö°¡ Àִ °ÍÀ¸·Î »ý°¢µÈ´Ù. À¯Àü¿äÀÎ, È£¸£¸óÀÇ ¿µÇâ, È¯°æ¿ä¼Ò°¡ Á¾ÇÕÀûÀ¸·Î º¸Á¶ T¼¼Æ÷¿Í B¼¼Æ÷¸¦ È°¼ºÈ­½ÃÄѼ­ ¿©·¯ °¡Áö ÀÚ°¡Ç×üµé, Áï Ãµ¿¬ DNA, ÀÌÁß°¡´Ú DNA, ¿Ü°¡´Ú DNA, RNA, ÇٴܹéÁú µî°ú °°Àº ÇÙ Ç׿ø¿¡ ´ëÇÑ Ç×ü, ºñÇÙÇ׿ø¿¡ ´ëÇÑ ¿©·¯ °¡Áö Ç×ü°¡ ½ñ¾ÆÁ® ³ª¿Â´Ù. ÀÌ Áß ÀÌÁß°¡´Ú DNA¸¦ Æ÷ÇÔÇÑ ¼øÈ¯¸é¿ªº¹ÇÕü°¡ ÄáÆÏ¿¡ Ä§ÂøÇÏ¿© ¼Õ»óÀ» ÀÏÀ¸Å°´Âµ¥ °ü¿©ÇÑ´Ù. DNA¿Í ¿©·¯ °¡Áö ¼¼Æ÷¼ººÐ¿¡ ´ëÇÑ ÀÚ°¡¸é¿ªÁúȯÀ¸·Î ÀüÄáÆÏ±â¸¦ Ä§¹üÇÏ¿© ¿°ÁõÀ» ÀÏÀ¸Å²´Ù. ¿©·¯ ÀÚ°¡Ç׿ø¿¡ ´ëÇÑ ¸é¿ª¹ÝÀÀ¿¡ ÀÇÇÑ Ç×üÀÇÁ¸¼º ¸é¿ª¹ÝÀÀ°ú ¸é¿ªº¹ÇÕü ¹ÝÀÀÀ¸·Î Å丮ÄáÆÏ¿°, Ç÷°ü¿°, °üÀý¿° ¹× ºóÇ÷À» µ¿¹ÝÇÑ´Ù.
¿µ¹® systemic circulation ÇÑ±Û Ã¼¼øÈ¯
¼³¸í   
  ¿Þ½É½Ç¿¡¼­ ½Åü¸¦ µ¹¾Æ ¿À¸¥½É¹æ±îÁöÀÇ ¼øÈ¯À» ÀǹÌÇϸç, ¿Þ½É½Ç ¡æ ´ëµ¿¸Æ ¡æ µ¿¸Æ ¡æ ¸ð¼¼Ç÷°ü ¡æ Á¤¸Æ ¡æ ´ëÁ¤¸Æ ¡æ ¿À¸¥½É¹æÀǠȸ·Î¸¦ ¼øÈ¯ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • systemic amyloidosis
    Àü½Å¾Æ¹Ð·ÎÀ̵åÁõ
  • amyloidosis
    ¾Æ¹Ð·ÎÀ̵åÁõ
  • endocardial amyloidosis
    ½É(Àå)³»¸·¾Æ¹Ð·ÎÀ̵åÁõ
  • generalized amyloidosis
    Àü½Å¾Æ¹Ð·ÎÀ̵åÁõ
  • nodular amyloidosis
    °áÀý¾Æ¹Ð·ÎÀ̵åÁõ
  • primary amyloidosis
    ¿ø¹ß¾Æ¹Ð·ÎÀ̵åÁõ
  • senile amyloidosis
    ³ë³â¾Æ¹Ð·ÎÀ̵åÁõ
  • antigen-reactive cell
    Ç׿ø¹ÝÀÀ¼¼Æ÷
  • C-reactive protein
    C-¹ÝÀÀ´Ü¹éÁú
  • reactive angioendotheliomatosis
    ¹ÝÀÀÇ÷°ü³»ÇÇÁ¾Áõ
  • reactive arthritis
    ¹ÝÀÀ°üÀý¿°
  • reactive attachment disorder
    ¹ÝÀÀ¼º¾ÖÂøÀå¾Ö
  • reactive bone excrescence
    ¹ÝÀÀ»Àµ¹Ãâ
  • reactive depression
    ¹ÝÀÀ¿ì¿ïÁõ
  • reactive fibrosis
    ¹ÝÀÀ¼¶À¯È­
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amyloidosis
    ¾Æ¹Ð·ÎÀ̵åÁõ
  • systemic circulation
    ¿Â¸ö¼øÈ¯, ü¼øÈ¯
  • systemic disease
    Àü½Åº´
  • systemic embolism
    Àü½Å»öÀüÁõ
  • systemic hypotension
    Àü½ÅÀúÇ÷¾Ð
  • systemic infection
    Àü½Å°¨¿°
  • systemic erythematosus lupus
    Àü½ÅÈ«¹Ý·çǪ½º
  • systemic reaction
    Àü½Å¹ÝÀÀ
  • systemic sclerosis
    Àü½Å°æÈ­Áõ
  • systemic inflammatory response syndrome
    Àü½Å¿°Áõ¹ÝÀÀÁõÈıº
  • systemic treatment
    Àü½ÅÄ¡·á
  • systemic therapy
    Àü½Å¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • systemic amyloidosis
    Àü½Å¾Æ¹Ð·ÎÀ̵åÁõ
  • amyloidosis
    ¾Æ¹Ð·ÎÀ̵åÁõ
  • endocardial amyloidosis
    ½ÉÀå³»¸·¾Æ¹Ð·ÎÀ̵åÁõ
  • generalized amyloidosis
    Àü½Å¾Æ¹Ð·ÎÀ̵åÁõ
  • nodular amyloidosis
    °áÀý¾Æ¹Ð·ÎÀ̵åÁõ
  • primary amyloidosis
    ¿ø¹ß¾Æ¹Ð·ÎÀ̵åÁõ
  • senile amyloidosis
    ³ëÀξƹзÎÀ̵åÁõ
  • antigen-reactive cell
    Ç׿ø¹ÝÀÀ¼¼Æ÷
  • reactive angioendotheliomatosis
    ¹ÝÀÀÇ÷°ü³»ÇÇÁ¾Áõ
  • reactive arthritis
    ¹ÝÀÀ°üÀý¿°
  • reactive perforating collagenosis
    ¹ÝÀÀ°üÅë¾Æ±³ÁúÁõ
  • reactive depression
    ¹ÝÀÀ¿ì¿ïÁõ
  • reactive attachment disorder
    ¹ÝÀÀ¾ÖÂøÀå¾Ö, ¹ÝÀÀ¾ÖÂøº´
  • reactive bone excrescence
    ¹ÝÀÀ»Àµ¹Ãâ
  • reactive fibrosis
    ¹ÝÀÀ¼¶À¯Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reactive systemic amyloidosis
    ¹ÝÀÀ¼º Àü½Å À¯ÀüºÐÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary systemic amyloidosis
    ¿ø¹ß¼º Àü½Å À¯ÀüºÐÁõ
  • amyloidosis
    ¾Æ¹Ð·ÎÀ̵åÁõ, À¯ÀüºÐÁõ
  • amyloidosis
    ¾Æ¹Ð·ÎÀ̵åÁõ, À¯ÀüºÐÁõ.
  • amyloidosis
    ¾Æ¹Ð·ÎÀ̵åÁõ(¡­ñø), À¯ÀüºÐÁõ(ëºîþÝÏñø)
  • amyloidosis
    À¯ÀüºÐÁõ
  • amyloidosis cutis
    ÇǺξƹзÎÀ̵åÁõ
  • amyloidosis primary
    ¿ø¹ß¼º(ê«Û¡àõ) ¾Æ¹Ð·ÎÀ̵åÁõ.
  • amyloidosis ulcer
    À¯ÀüºÐÁõ(ëºîþÝÏñø) ±Ë¾ç(Ï÷åË)
  • generalized amyloidosis
    Àü½Å¼º ¾Æ¹Ð·ÎÀ̵åÁõ.
  • hepatic amyloidosis
    °£¾Æ¹Ð·ÎÀ̵åÁõ.
  • hereditary cerebral hemorrhages with amyloidosis(hchwa)
    À¯Àü¼º ³úÃâÇ÷, ¾Æ¹Ð·ÎÀ̵åÁõ¼º
  • primary amyloidosis
    ¿ø¹ß(¼º) ¾Æ¹Ð·Î À̵åÁõ.
  • primary amyloidosis
    ¿ø¹ß(¼º)(ê«Û¡(àõ)) ¾Æ¹Ð·Î À̵åÁõ
  • primary localized cutaneous amyloidosis
    ¿ø¹ß¼º ±¹¼Ò ÇǺΠÀ¯ÀüºÐÁõ
  • pulmonary amyloidosis
    Æó¾Æ¹Ð·ÎÀ̵åÁõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reactive systemic amyloidosis
    ¹ÝÀÀ¼º Àü½Å À¯ÀüºÐÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary systemic amyloidosis
    ¿ø¹ß¼º Àü½Å À¯ÀüºÐÁõ
  • secondary systemic amyloidosis
    ¼Ó¹ß¼º Àü½Å¼º(áÙÛ¡àõîïãóàõ) ¾Æ¹Ð·ÎÀ̵åÁõ.
  • secondary systemic amyloidosis
    ¼Ó¹ß¼º Àü½Å¼º(áÙÛ¡àõîïãóàõ) ¾Æ¹Ð·ÎÀ̵åÁõ(¡­ñø)
  • systemic amyloidosis
    Àü½Å¼º ¾Æ¹Ð·ÎÀ̵åÁõ
  • amyloidosis
    ¾Æ¹Ð·ÎÀ̵åÁõ, À¯ÀüºÐÁõ.
  • amyloidosis
    ¾Æ¹Ð·ÎÀ̵åÁõ(¡­ñø), À¯ÀüºÐÁõ(ëºîþÝÏñø)
  • amyloidosis
    À¯ÀüºÐÁõ
  • amyloidosis
    ¾Æ¹Ð·ÎÀ̵åÁõ, À¯ÀüºÐÁõ
  • amyloidosis cutis
    ÇǺξƹзÎÀ̵åÁõ
  • amyloidosis primary
    ¿ø¹ß¼º(ê«Û¡àõ) ¾Æ¹Ð·ÎÀ̵åÁõ.
  • amyloidosis ulcer
    À¯ÀüºÐÁõ(ëºîþÝÏñø) ±Ë¾ç(Ï÷åË)
  • cardiac amyloidosis
    ½É¾Æ¹Ì·ÎÀ̵µÁõ À¯ÀüºÐÁõ(ãý-ñø ëºîþÝÏñø)
  • cutaneous amyloidosis
    ÇǺÎÀ¯ÀüºÐÁõ
  • endocardial amyloidosis
    ½É³»¸·¾Æ¹Ð·ÎÀ̵åÁõ.
  • generalized amyloidosis
    Àü½Å¼º ¾Æ¹Ð·ÎÀ̵åÁõ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amyloidosis
    ¾Æ¹Ð·ÎÀ̵åÁõ(ñø)
  • C-reactive protein
    C¹ÝÀÀ(Úãëë) ´Ü¹éÁú(Ó±ÛÜòõ)
  • reactive enzyme centrifugetion
    ¹ÝÀÀÈ¿¼Ò ¿ø½ÉºÐ¸®(Úãëëý£áÈêÀãýÝÂ×î)
  • reactive hemolysis
    ¹ÝÀÀ¼º ¿ëÇ÷(ÚãëëàõéÁúì)
  • reactive lysis
    ¹ÝÀÀ¼º ¿ëÇØ(ÚãëëàõéÁú°)
  • reactive residue
    ¹ÝÀÀ¼º Àܱâ(ÚãëëàõíÑÐñ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amyloidosis
    ¾Æ¹Ð·ÎÀ̵åÁõ, À¯ÀüºÐÁõ
  • C-reactive protein
    C-¹ÝÀÀ¼º´Ü¹éÁú
  • reactive bone excrescence
    ¹ÝÀÀ¼º°ñµ¹Ãâ
  • reactive fibrosis
    ¹ÝÀÀ¼º¼¶À¯È­
  • reactive hyperemia
    ¹ÝÀÀ¼ºÃæÇ÷
  • reactive interface
    ¹ÝÀÀ¼ºÁ¢Ã˸é
  • systemic
    Àü½Å¼ºÀÇ
  • systemic blood pressure
    üÇ÷¾Ð
  • systemic infection
    Àü½Å¼º°¨¿°(Áõ)
  • systemic lesion
    Àü½Å¼ºº´º¯
  • systemic lupus erythematosus
    Àü½Å¼ºÈ«¹Ý¼º·çǪ½º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AL absolute latency; acinar lumen; acute leukemia; adaptation level; albumin; alcoholism [and other dru...
DAA decompensated autonomous adenoma; dementia associated with alcoholism; dialysis-associated amyloidos...
HCHWA hereditary cerebral hemorrhage with amyloidosis
PSS painful shoulder syndrome; physiologic saline solution; porcine stress syndrome; primary Sjogren syn...
SMCD senile macular choroidal degeneration; systemic mast cell disease; systemic meningococcal disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AL Amyloidosis
DRA Dialysis related amyloidosis
FAF Familial amyloidosis, Finnish type
HCHWA-D Hereditary cerebral haemorrhage with amyloidosis, Dutch type
MAP Mean systemic arterial pressure
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • endocardial amyloidosis
    ½É³»¸· ¾Æ¹Ð·ÎÀ̵åÁõ
  • hereditary amyloidosis
    À¯Àü¼º À¯ÀüºÐÁõ
    1. À¯Àü¿¡ ÀÇÇØ ¿ø¼¶À¯¼º ´ç ´Ü¹éÀÌ ÇǺÎ, Á¡¸·, ³»ºÎ Àå±â¿¡ ħÀüµÇ´Â º´. 2. À¯ÀüÀûÀ¸·Î ½ÅüÀÇ °¢Á¾ ºÎÀ§¿¡ ¾Æ¹Ð·ÎÀ̵å
  • primary amyloidosis
    ¿ø¹ß¼º À¯ÀüºÐÁõ, ¿ø¹ß ¾Æ¹Ð·ÎÀ̵åÁõ, ¿ø¹ß¼º ¾Æ¹Ð·ÎÀ̵åÁõ
  • acquired reactive perforating dermatosis
    ÈÄõ¼º ¹ÝÀÀ¼º õ°ø¼º ÇǺκ´
  • C-reactive protein
    C-¹ÝÀÀ ´Ü¹é, C-¹ÝÀÀ¼º ´Ü¹éÁú
  • percent reactive antibody test
    ÆÛ¼¾Æ® ¹ÝÀÀ Ç×ü °Ë»ç
  • reactive bone excrescence
    ¹ÝÀÀ¼º °ñ µ¹Ãâ
  • reactive disease
    ¹ÝÀÀ¼º Áúȯ
  • reactive hyperemia
    ¹ÝÀÀ¼º ÃæÇ÷
    Ç÷·ù¸¦ ÀϽÃÀûÀ¸·Î Á¤Áö½ÃŲ Ç÷·ù Â÷´ÜÀ» ÇØÁ¦ÇÑ ÈÄ¿¡ ºÎºÐÀûÀ¸·Î Ç÷¾×ÀÌ °úÀ×À¸·Î µÇ´Â °Í.
  • reactive lesion
    ¹ÝÀÀ¼º º´¼Ò
  • reactive schizophrenia
    ¹ÝÀÀ¼º ºÐ¿­º´
    ¾ç¼ºÀÇ ¿¹Èİ¡ ±â´ëµÇ´Â, ÁַΠȯ°æ Á¶°Ç¿¡ ±âÀÎµÈ Á¤½Å ºÐ¿­.
  • portal-systemic venous collateral circulation
    °£ ¹®¸Æ-Àü½Å Á¤¸ÆÀÇ ÃøÁö ¼øÈ¯
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °øÇÇÁõ
  • surgically contructed systemic-pulmonary shunts
    ¿Ü°úÀûÀ¸·Î Çü¼ºÇØÁØ Àü½Å-Æó¼º ´Ü¶ô
  • systemic adverse effect
    Àü½Å¼º ºÎÀÛ¿ë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
arthritis, reactive An abacterial form of arthritis developing after infection at a site distant from the affected joint or joints. The causative bacteria cannot be cultured from synovial specimens but bacterial antigens have been demonstrated in cells from the synovial fluid and membrane. It often follows yersinia infection.
(12 Dec 1998)
brief reactive psychosis <psychiatry> A brief display of psychotic behaviour that lasts for at least several hours, but not more than one week. Typically these reactions are brought on by periods of increased stress (for example death of a loved one).
Symptoms include delusions, hallucinations, disordered thinking, impaired speech and bizarre dress.
(27 Sep 1997)
reactive arthritis Reiter's syndrome is also called reactive arthritis since it is thought to involve the immune system which is reacting to the presence of bacterial infections in the genital, urinary, or gastrointestinal systems. Accordingly, certain people's immune systems are genetically primed to react aberrantly when these areas are exposed to certain bacteria. The aberrant reaction of the immune system leads to inflammation in the joints and eyes.
(12 Dec 1998)
reactive astrocyte <cell biology> A round to oval astrocyte cell with abundant cytoplasm containing glial filaments and an eccentric nucleus; may contain two nuclei in the cell hypertrophy of astrocytes.
Synonym: gemistocyte, gemistocytic cell, reactive astrocyte, reactive cell.
(05 Mar 2000)
reactive attachment disorder Markedly disturbed and developmentally inappropriate social relatedness that begins before age 5 and is associated with grossly pathological child care. The child may persistently fail to initiate and respond to social interactions in a developmentally appropriate way (inhibited type) or there may be a pattern of diffuse attachments with nondiscriminate sociability (disinhibited type).
(12 Dec 1998)
reactive cell <cell biology> A round to oval astrocyte cell with abundant cytoplasm containing glial filaments and an eccentric nucleus; may contain two nuclei in the cell hypertrophy of astrocytes.
Synonym: gemistocyte, gemistocytic cell, reactive astrocyte, reactive cell.
(05 Mar 2000)
reactive depression A psychological state occasioned directly by an intensely sad external situation (frequently loss of a loved person), relieved by the removal of the external situation (e.g., reunion with a loved person).
(05 Mar 2000)
reactive hyperaemia Hyperaemia following the arrest and subsequent restoration of the blood supply to a part.
(05 Mar 2000)
reactive inhibition Tendency toward a lessened strength of response due to practice or activity. It is independent of the effect of reward and is a direct function of time interval since the last response and the number of preceding responses.
(12 Dec 1998)
reactive oxygen species Reactive intermediate oxygen species including both radicals and non-radicals. These substances are constantly formed in the human body and have been shown to kill bacteria and inactivate proteins, and have been implicated in a number of diseases. Scientific data exist that link the reactive oxygen species produced by inflammatory phagocytes to cancer development.
(12 Dec 1998)
reactive perforating collagenosis A rare skin disorder characterised by extrusion of collagen fibres through the epidermis; usually begins in infancy or childhood and appears clinically as recurrent umbilicated papules that resolve spontaneously. The condition may be inherited or acquired, the latter differing from Kyrle's disease because follicular involvement is absent.
(05 Mar 2000)
reactive schizophrenia Those forms of severe schizophrenic disorders which are distinguished from process schizophrenia by their more acute onset, greater relation to environmental stress, and better prognosis.
(05 Mar 2000)
child reactive disorders Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns.
(12 Dec 1998)
cold-reactive antibody See: cold agglutinin.
(05 Mar 2000)
C-reactive protein <protein> This blood test is used as an indicator of acute inflammation. C-reactive protein is a protein of the pentraxin family, produced by the liver during periods of inflammation and detectable in serum in various disease conditions particularly during the acute phase of immune response. Normally C-reactive protein should be negative in the bloodstream.
C-reactive protein is synthesised by hepatocytes and its production may be triggered by prostaglandin E1 or parogen. It consists of five polypeptide sub units forming a molecule of total molecular weight 105 kD. It binds to polysaccharides present in a wide range of bacterial, fungal and other cell walls or cell surfaces and to lecithin and to phosphoryl or choline containing molecules. It is related in structure to Serum Amyloid. And C polysaccharide.
Conditions which can cause a positive C-reactive protein include: rheumatoid arthritis, lupus, pneumococcal pneumonia, rheumatic fever, cancer, tuberculosis and myocardial infarction.
A positive C-reactive protein may also be seen in the later half of pregnancy and in some who are taking birth control pills.
See: acute phase proteins
(06 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reactive
    (Àڱؿ¡ ´ëÇØ)¹Î°¨ÇÑ;¹ÝÀÀÀÌ ºü¸¥;¹Ýµ¿(º¹°í)ÀûÀÎ;¹Ý¹ßÀûÀÎ;¹ÝÀÀÀûÀÎ;¹ÝÀÛ¿ëÀûÀÎ;~ly
  • systemic
    °èÅëÀÇ
  • systemic
    Á¶Á÷(°èÅë)ÀÇ;Àü½ÅÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á